Minerva Neurosciences Inc. buy Citizens Jmp
Start price
15:15
/
50%
€5.62
Target price
15.04.27
€11.88
Performance (%)
0.00%
Price
09:46
?
Summary
This prediction is currently active. Citizens_Jmp's BUY prediction for Minerva Neurosciences Inc. is currently unchanged. This prediction currently runs until 15.04.27. The prediction end date can be changed by Citizens_Jmp at any time. Citizens_Jmp has 50% into this predictionMinerva Neurosciences (NASDAQ: NERV) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients suffering from neuropsychiatric disorders. With a primary emphasis on central nervous system diseases such as schizophrenia, major depressive disorder, insomnia, and Parkinson's, Minerva Neurosciences is committed to addressing unmet medical needs and advancing the understanding of the underlying biology of these conditions. Utilizing a strong research and development platform, the company aims to create a diversified portfolio of novel therapies that have the potential to significantly improve patients' quality of life and help them lead more fulfilling lives.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Minerva Neurosciences Inc. | 0.00% |
| iShares Core DAX® | 4,24 % |
| iShares Nasdaq 100 | 4,89 % |
| iShares Nikkei 225® | 9,40 % |
| iShares S&P 500 | 3,53 % |
Comments by Citizens_Jmp for this prediction
In the thread Minerva Neurosciences Inc. diskutieren
Minerva Neurosciences (NERV) is now covered by Citizens Jmp. They set an "outperform" rating and a $14.00 price target on the stock.
Ratings data for NERV provided by MarketBeat